Mark A. Velleca, Director at G1 Therapeutics, Inc. (GTHX), sold 30,000 shares at $19.10 ($597K) on 2021-05-11, disclosed to the SEC on 2021-05-13.
Open-market sale of $597k GTHX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.10 | 10,000 | $191K | 32.0% |
| 2 | $20.07 | 10,000 | $201K | 33.6% |
| 3 | $20.54 | 10,000 | $205K | 34.4% |
| Total | $19.90 avg | 30,000 | $597K | 100% |
| Filing → |
| GTHX | SELL | 2022-09-22 | $270K | — | Filing → |
| GTHX | SELL | 2022-08-18 | $1.0M | — | Filing → |
| GTHX | SELL | 2021-07-15 | $946K | — | Filing → |